Renal Replacement Therapy When and how much… Joannidis... · Renal Replacement Therapy When and...
Transcript of Renal Replacement Therapy When and how much… Joannidis... · Renal Replacement Therapy When and...
Renal Replacement TherapyWhen and how much…When and how much…
M. JoannidisMedizinische Intensivstation
Universitätsklinik für Innere Medizin IMedizin Universität Innsbruck
Early vs late start of RRT
Liu et al, CJASN 2006
Initiation of CRRTafter the “millennium party”
Large (n>100), randomized trials renal replacement therapy in ICU patients with AKI endpoint - mortality
• BUN 50 mg/dl, Crea 3.5 mg/dl (Ronco C, Lancet 2000)• BUN 85 mg/dl, Crea 4.5 mg/dl (Mehta R, Kidney Int 2001)• BUN 90 mg/dl, Crea 5.0 mg/dl (Schiffl H, NEJM 2002)• BUN 83 mg/dl, Crea 4.3 mg/dl (Saudan P, Kidney Int 2006)• BUN 76 mg/dl, Crea 4.3 mg/dl (Tolwani A, JASN 2008)• BUN 66 mg/dl (ATN-VA, NEJM 2008)• BUN 63 mg/dl, Crea 3.4 mg/dl (Faulhaber-;NDT 2009)• BUN 64 mg/dl, Crea 3.4 mg/dl (RENAL, NEJM 2009)
Group 1 (late):• crea> 5mg/dl or K>5.5 mmol/l
Group 2 (early):• Uo < 100ml for 8h despite
furosemide 50mg
J Card Surgery 2004; 19:17-20
CVVHDF dose?
J Card Surgery 2004; 19:17-20
Timing of RRT in Acute Renal Failure -Meta Analysis
Seabra VF. AJKD 2008
Should we use RIFLE Criteria for initiation?
Bellomo R , Crit Care 2004
Late initiation of renal replacement therapy is associated with worse outcomes in
acute kidney injury after major abdominal surgery
RIFLE Risk however…
Shiao C-C, Crit Care 2009
further problems:•CKD 55% vs 28% p<0.008•Baseline Crea 2.1 vs 1.3 mg/dl
RIFLE Failure
Should we use RIFLE Criteria for initiation?
No association between RIFLE stage at start of CRRT and survival!survival!
Maccariello et al, Intensive Care Med 2007
RIFLE classification in patients with acutekidney injury in need of renal replacement
therapy
Maccariello et al, Intensive Care Med 2007
What are relevant paramters for initiation?
• Urea?• Creatinine?• Creatinine?• Urinary Output?• Volume overload?
„Unguided fluid administration may be hazardous….“
Fluid Management in ALIFluid balance / week
Conserv. Strategy (n=503): Liberal Strategy (n=498):
-136 (+ 491) ml + 6992 (+502) ml
ARDS Clinical Network Trial, NEJM 2006
Effect on fluid overload on survival (PICARD Study)
Mortality rate by final fluid accumulation relative tobaseline weight and stratified by dialysis status
Bouchard J et al, Kidney Int 2009610 Pat. (65% RRT), 5 Academic Centres
Start of CRRT in Start of CRRT in SEPSISSEPSIS
•• AKIAKI
•• IntubationIntubation
•• vasopressorsvasopressors
DeathDeath
•• IRVIRV
•• AKIAKI
Clinical trials -CRRT in Sepsis
• randomized trial with 24 pt. in early septic shock
• 48 h isovolemic CVVH 2L/h vs. stand. med. treatment
• 72 h observation period• 72 h observation period• primary parameters:
– C3a + C5a, interleukins 6, 8 + 10, TNF
– MODS
Cole L et al., Crit Care Med 2002
Clinical trials -CRRT in Sepsis
• randomized trial with 24 pt. in early septic shock
• 48 h isovolemic CVVH 2L/h vs. stand. med. treatment
• 72 h observation period
• No significant changes in cytokines or C3a + C5a by CVVH
• MODS – no difference between both groups.• 72 h observation period
• primary parameters: – C3a + C5a, interleukins 6, 8
+ 10, TNF– MODS
between both groups.• CVVH does not result in
improvement of oxygenation or hemodynamics
Cole L et al., Crit Care Med 2002
Clinical trials -CRRT in Sepsis
• randomized trial with 24 pt. in early septic shock
• 48 h isovolemic CVVH 2L/h vs. stand. med. treatment
• 72 h observation period
• No significant changes in cytokines or C3a + C5a by CVVH
• MODS – no difference between both groups.• 72 h observation period
• primary parameters: – C3a + C5a, interleukins 6, 8
+ 10, TNF– MODS
between both groups.• CVVH does not result in
improvement of oxygenation or hemodynamics
Cole L et al., Crit Care Med 2002
Impact of continuous venovenous hemofiltration on organ failureduring the early phase of severe sepsis.
A randomized controlled trial.
25 ml/kg/h
SEPSIS>1 organ failurewithin 24 h
Parameters at time of Randomisation:
Crea = 2.1 mg/dlBUN= 42 mg/dl
Payen D, Crit Care Med 2009
ml/kg/h (96h)
BUN= 42 mg/dlpH= 7.33UO= 1.5 l/d (~0.8 ml/kg/h)
Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis.
A randomized controlled trial
Payen D, Crit Care Med 2009
Impact of continuous venovenous hemofiltration on organ failureduring the early phase of severe sepsis.
A randomized controlled trial
Payen D, Crit Care Med 2009
Early RRT …?
Consider Adverse Effects of RRT
• Loss of trace elements (e.g. selenium)• Loss of vitamines (e.g. thiamine, vit C)• Loss of vitamines (e.g. thiamine, vit C)• Loss of nutrients (AA)• Loss of heat (is cooling good for sepsis?)• Complications with catheter• Anticoagulation (e.g. heparin)
Murphy´s law
Never try to repair something that is not broken….broken….
Initiation of CRRT A worldwide practice survey (B.E.S.T kidney)
• Oliguria/anuria 70.2%
• High urea/creatinine 53.0%• High urea/creatinine 53.0%
• Metabolic acidosis 43.6%
• Fluid overload 36.7%
Uchino et al, Intensive Care Med 2007
Dose of RRT?
2007
The world of RRT
Dose of RRT2007
CVVH Daily IHDCVVH35 ml/kg/h (80%)
(Ronco C, Lancet 2000)
Daily IHDweekly KT/V 5.8
(Schiffl H, NEJM 2002)
CVVHDF42 ml/kg/h
(Saudan P, Kidney Int 2006)
Dose in RRT(Questionaire in VIcenza course of Critical Care Nephrology)
Ricci, Z. et al. Nephrol. Dial. Transplant. 2006
n=1124IHD daily or SLED orCVVHDF 35 ml/kg/h
IHD every other day or SLED or
CVVHDF 20 ml/kg/h(~22 ml/kg/h delivered)
Numbers of Patients Enrolled in the Study, Randomly Assigned to a Treatment Group, and Included in the Analysis
CVVHDF
The RENAL Replacement Therapy Study Investigators. N Engl J Med 2009;361:1627-1638
40 ml/kg/hCVVHDF 25 ml/kg/h
Dose delivered84% 88%
~33ml/kg/h ~22 ml/kg/h
Kaplan-Meier Estimates of the Probability of Death
The RENAL Replacement Therapy Study Investigators. N Engl J Med 2009;361:1627-1638
Indications:60% oliguria (<400ml/d)40-50% crea>3.4 mg/dl,BUN>70mg/dl44% severe organ edema35% acidemia
RENAL-specific aspectsHigher Intensity Lower Intensity p value
Male Age
66%64.7
64%64.4
Time in ICU before randomization
48.4 h 54.5 hrandomization
Weight Sepsis
80.8 kg49.9%
80.5 kg48.9%
Dose delivered 84%~34 ml/kg/h
88%~22 ml/kg/h
<0.001
Filters uses daily 0.93 0.84 <0.001
Hypophosphatemia 65% 54% <0.0001
CRRT Dose: how much is enough?
35
42
2025
25
30
35
40
45
Dos
e m
l/kg/
h
CVVHDFCVVH
13
20
0
5
10
15
20
25
Dos
e m
l/kg/
h
< 1999 2000 2006 2008 2009
Ron
co (
300)
Sau
dan
(200
)
AT
N (
1100
)
RE
NA
L(15
00)
DIALYSISDOSE AND SEVERITY OF DIALYSISDOSE AND SEVERITY OF DISEASEDISEASE
100100
8080high K t / Vhigh K t / V
% S
urvi
val
% S
urvi
val
6060
4040
2020
000 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 200 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
CCF ICU ARF ScoreCCF ICU ARF Score
SurvivalSurvivalaccord. CCF Scoreaccord. CCF Score
low K t / Vlow K t / V
Paganini, Am J Kidney Dis 1996Paganini, Am J Kidney Dis 1996
Should we apply a different dose in severe sepsis/septic shock?
Sepsis
CARSIL-1TNF
IL-6
PAF
endothelin
C3a/C5
Modulation of sepsis byremoval of mediators??
SIRS
CARSIL-1 IL-6
IL-10IL-2 ra
sTNFR
endothelin
Elimination (%) in Correlation toHalf-life und Elimination-coefficient
Filtrate S.C. 15 min 30 min 60 min 120min
1 l/h 0,1 0,3 0,6 1,2 2,4
1 l/h 0,25 1 2 4 8
t1/2
1 l/h 0,25 1 2 4 8
2 l/h 0,1 0,6 1,2 2,4 4,8
2 l/h 0,25 2 4 8 16
3 l/h 0,1 0,9 1,8 3,6 7,2
3 l/h 0,25 3 6 12 24
8 l/h 0,25 8 16 32 68Kierdorf H, Kidney Int 1999
Size, Kinetics und Elimination of Cytokines
Cytokine Molecular-weight (kD)
Half-life (min) Sieving-coefficient
TNF MonomerTrimer
1752
6-710-17, ~15
0-1,00-0,252 10-17, ~15 0-0,2
IL-1 18 6-10 0,07- 0,42
IL-2 ~ 10 ? 0,1-0,25
IL-6 26 6-10 0,01 – 0,32
IL-8 6-8 ~ 6 0,0 – 0,48
Kierdorf H, Kidney Int 1999
Elimination (%) in Correlation toHalf-life und Elimination-coefficient
Filtrate S.C. 15 min 30 min 60 min 120min
1 l/h 0,1 0,3 0,6 1,2 2,4
1 l/h 0,25 1 2 4 8
t1/2
1 l/h 0,25 1 2 4 8
2 l/h 0,1 0,6 1,2 2,4 4,8
2 l/h 0,25 2 4 8 16
3 l/h 0,1 0,9 1,8 3,6 7,2
3 l/h 0,25 3 6 12 24
8 l/h 0,25 8 16 32 68Kierdorf H, Kidney Int 1999
Cytokine plasma-concentrations during CVVHF
De Vriese AN, JASN 1999
Filter exchanged
CVVH UF=2L/h
Clinical trials -CRRT in Sepsis
Cole L et al., Crit Care Med 2002
The impact of long-term haemofiltration (continuousveno-venous haemofiltration) on cell-mediated
immunity during endotoxaemia
Oxidative burstSerum IL-6
Endotox Endotox
CVVH 35 ml/kg/h, porcine ETx model
Toft et al 2007, Acta Anaesthesiol Scand
Endotox
Ko
Endotox + CVVH
Endotox + CVVH
Endotox
Mortality in the Prespecified Subgroups and among All Patients
The RENAL Replacement Therapy Study Investigators. N Engl J Med 2009;361:1627-1638
Should we apply a different dose in severe sepsis/septic shock?
Summary
• Dose: 1) „individualised“ dose!2) minimal dose:
>20-25ml/kg/h CRRT>1.3 Kt/V (4h) IHD
• Inititation:
>1.3 Kt/V (4h) IHD
early:• oliguria (persistent!!)• severe organ edema• acidosis• BUN >50-80 mg% (?)
-> but not too early!
The Hannover Dialysis Outcome study: comparison of standard versus intensified extended dialysis for
treatment of patients with acute kidney injury in the intensive care unit
SLED daily (SED)BUN 60-75 mg/dl
N=76
SLED intensified (IED)BUN < 45 mg/dl
n=81
Faulhaber-Walter R, Nephrol Dial Transplant. 2009 Jul;24(7):2179-86
The VA/NIH Acute Renal Failure Trial Network
Delivered Dialysis Dose Delivered CVVHDF Dose
N Engl J Med 2008;359:7-20
Discontinuation of continuous renal replacement therapy
(B.E.S.T kidney)
436 ml/dw/o diuretics
Uchino et al, Crit Care Medicine 2009
2330 ml/dw diuretics
High-volume HF (HVH)
• 11 patients in septic shock• Design: randomized, cross-over
HVHF (8h) Standard HF (8h)HVHF (8h)
QB=300 ml/min, UF 6L/h
1,6 m² AN 69 (polyacrylonitril)
Cole L, Int. Care Med 2001
Standard HF (8h)
QB=200 ml/min, UF 1L/h
1,2 m² AN 69 (polyacrylonitril)
reductions in C3a,C5a, IL-10 (~ 80%)
reduced requirements of vasopressors
IL6 and Il1-ra in septic shock treated with HVH
• RCT: CVVH (2l/h, n=18) vs. (6l/h, n=15) over 6 h
Ghani et al, Nephrology 2006
significant reduction of IL-6 after HVH
0,6
0,8
1
Sie
ving
Coe
ffici
ent
HighFlux
High Cut-Off
HF, UF=1L/h, t=2h
Median (25th-75th percentiles)
Ex vivo Sieving Coefficients of Cytokines
0
0,2
0,4
1000 10000 100000
Sie
ving
Coe
ffici
ent
Molecular Weight [Da]
Albumin
TNFa
IL-10
IL-6
IL-1
ß2m
HighFlux
data from Uchino et al.
Pilot Study of CRRT with High Cut-off Membranes (~60kD) on the need for norepinephrine in septic Patients with acute
renal failure
Morgera S et.al , Critical Care Medicine 2006
Pilot Study of CRRT with High Cut-off Membranes (~60kD) on the need for norepinephrine in septic Patients with acute
renal failure
Morgera S et.al , Critical Care Medicine 2006
´́́́
Urea-distribution volume and total body water in critically ill patients
Ikitzler F , Kidney Int 2004Ikitzler F , Kidney Int 2004
Urea production rateCatabolic stateVolume of distribution
Timing and DosingB
UN
time
higher volume of distribution
CRRT
Timing and DosingB
UN
time
higher dose
earlier start
CRRT
Timing and DosingB
UN
time
very early start
higher dose
earlier start
volume of distribution (urea)Urea production rateCatabolic state
volume of distribution (urea)
Timing and Dosing